Sepsis-3: Insights from the Lead Author

Tipo de sala

Permanente

Nombre

Este campo es obligatorio.

Apellidos

Este campo es obligatorio.

Dirección de correo electrónico

Este campo es obligatorio.

Empresa

Este campo es obligatorio.

Campos obligatorios

Pago a través de

Antes de comprar su entrada, revise los requisitos técnicos para participar en el evento aquí.

Si ya está registrado y no puede localizar su email de confirmación de registro, ¡haga clic aquí!

Prueba de configuración del sistema. ¡Haga clic aquí!

Marvyn Singer, MD

Mervyn Singer, MB BS, MD, FRCP (Lon), FRCP (Edin), FFICM, is Professor of Intensive Care Medicine and Director of the Bloomsbury Institute of Intensive Care Medicine at University College London, UK, since 2001. He was Senior Investigator at the National Institute of Health Research from 2009 to 2017 and is currently the Sepsis Topic Advisor for NICE. Dr Singer was Co-chair of the Sepsis-3 Consensus Task Force and lead author of "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Agenda del evento

This special session features Dr. Mervyn Singer, lead author of Sepsis-3 guidelines and co-author of the new update to SOFA, SOFA-2.

In this session, Dr. Singer:

Outlines why the Sepsis-2 SIRS criteria are now regarded as outdated and inadequate.
Describes the development process of the Sepsis-3 guidelines.
Discusses the latest revisions to the SOFA score, known as SOFA-2.
Debunks the common sepsis denial rationales presented by payers.

Recording is available for 90 days after purchase.